ProShares Ultra NASDAQ Biotechnology
40 hedge funds and large institutions have $29M invested in ProShares Ultra NASDAQ Biotechnology in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 6 closing their positions.
Holders
40
Holders Change
+7
Holders Change %
+21.21%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
11
Reduced
8
Closed
6
Calls
$9.71M
Puts
$14.5M
Net Calls
-$4.78M
Net Calls Change
+$9.33M